My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2020/421 of 18 March 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, Lecanicillium muscarium (formerly ‘Verticillium lecanii’) strain Ve6, mepanipyrim, Metarhizium anisopliae (var. anisopliae) strain BIPESCO 5/F52, metconazole, metrafenone, Phlebiopsis gigantea strains FOC PG 410.3, VRA 1835 and VRA 1984, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium oligandrum M1, rimsulfuron, spinosad, Streptomyces K61 (formerly ‘S. griseoviridis’), Trichoderma asperellum (formerly ‘T. harzianum’) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly ‘T. harzianum’) strains IMI 206040 and T11, Trichoderma gamsii (formerly ‘T. viride’) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)

Commission Implementing Regulation (EU) 2020/421 of 18 March 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, Lecanicillium muscarium (formerly ‘Verticillium lecanii’) strain Ve6, mepanipyrim, Metarhizium anisopliae (var. anisopliae) strain BIPESCO 5/F52, metconazole, metrafenone, Phlebiopsis gigantea strains FOC PG 410.3, VRA 1835 and VRA 1984, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium oligandrum M1, rimsulfuron, spinosad, Streptomyces K61 (formerly ‘S. griseoviridis’), Trichoderma asperellum (formerly ‘T. harzianum’) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly ‘T. harzianum’) strains IMI 206040 and T11, Trichoderma gamsii (formerly ‘T. viride’) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)

Implementing Regulation (EU) 2020/421 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘30 April 2021’; (2) in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis strain MA 342, the date is replaced by ‘30 April 2021’; (3) in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by ‘30 April 2021’; (4) in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced by ‘30 April 2021’; (5) in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘30 April 2021’; (6) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘30 April 2021’; (7) in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘30 April 2021’; (8) in the sixth column, expiration of approval, of row 129, Clopyralid, the date is replaced by ‘30 April 2021’; (9) in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘30 April 2021’; (10) in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘30 April 2021’; (11) in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by ‘30 April 2021’; (12) in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘30 April 2021’; (13) in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by ‘30 April 2021’; (14) in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 April 2021’; (15) in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by ‘30 April 2021’; (16) in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by ‘30 April 2021’; (17) in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) strain QST 713, the date is replaced by ‘30 April 2021’; (18) in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘30 April 2021’; (19) in the sixth column, expiration of approval, of row 193, Bacillus thuringiensis subsp. aizawai strain ABTS-1857 and strain GC-91, the date is replaced by ‘30 April 2021’; (20) in the sixth column, expiration of approval, of row 194, Bacillus thuringiensis subsp. israeliensis (serotype H-14) strain AM65-52, the date is replaced by ‘30 April 2021’; (21) in the sixth column, expiration of approval, of row 195, Bacillus thuringiensis subsp. kurstaki strain ABTS 351, strain PB 54, strain SA 11, strain SA 12, strain EG 2348, the date is replaced by ‘30 April 2021’; (22) in the sixth column, expiration of approval, of row 197, Beauveria bassiana strain ATCC 74040, strain GHA, the date is replaced by ‘30 April 2021’; (23) in the sixth column, expiration of approval, of row 198, Cydia pomonella Granulovirus (CpGV), the date is replaced by ‘30 April 2021’; (24) in the sixth column, expiration of approval, of row 199, Lecanicillium muscarium (formerly Verticilium lecanii ) strain Ve 6, the date is replaced by ‘30 April 2021’; (25) in the sixth column, expiration of approval, of row 200, Metarhizium anisopliae var. anisopliae (formerly Metarhizium anisopliae ) strain BIPESCO 5/F52, the date is replaced by ‘30 April 2021’; (26) in the sixth column, expiration of approval, of row 201, Phlebiopsis gigantea strain VRA 1835, strain VRA 1984, strain FOC PG 410.3, the date is replaced by ‘30 April 2021’; (27) in the sixth column, expiration of approval, of row 202, Pythium oligandrum strain M1, the date is replaced by ‘30 April 2021’; (28) in the sixth column, expiration of approval, of row 203, Streptomyces K61 (formerly S. griseoviridis ) strain K61, the date is replaced by ‘30 April 2021’; (29) in the sixth column, expiration of approval, of row 204, Trichoderma atroviride (formerly T. harzianum ) strains IMI206040 and T11, the date is replaced by ‘30 April 2021’; (30) in the sixth column, expiration of approval, of row 206, Trichoderma harzianum Rifai strain T-22, strain ITEM 908, the date is replaced by ‘30 April 2021’; (31) in the sixth column, expiration of approval, of row 207, Trichoderma asperellum (formerly T. harzianum ) strain ICC012, strain T25, strain TV1, the date is replaced by ‘30 April 2021’; (32) in the sixth column, expiration of approval, of row 208, Trichoderma gamsii (formerly T. viride ) strain ICC080, the date is replaced by ‘30 April 2021’; (33) in the sixth column, expiration of approval, of row 210, Abamectin, the date is replaced by ‘30 April 2021’; (34) in the sixth column, expiration of approval, of row 213, Fenpyroximate, the date is replaced by ‘30 April 2021’.

Other acts of the same type
Regulation (EU) 2026/1395 of the European Parliament and of the Council of 17 June 2026 on applying a generalised scheme of tariff preferences and repealing Regulation (EU) No 978/2012Commission Implementing Regulation (EU) 2026/1391 of 16 June 2026 on the approval of an amendment to the product specification of the traditional speciality guaranteed Moules de bouchotCommission Implementing Regulation (EU) 2026/1311 of 15 June 2026 amending Implementing Regulation (EU) 2025/807 as regards administrative and minor changes to the Union authorisation of the biocidal product C(M)IT/MIT & Glutaraldehyde FormulationsCommission Regulation (EU) 2026/1314 of 15 June 2026 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1,4-dimethylnaphthalene, chlormequat, metribuzin, metribuzin-desamino-diketo (metribuzin-DADK), terbuthylazine and triclopyr in or on certain productsCommission Implementing Regulation (EU) 2026/1315 of 15 June 2026 setting out the content and practical arrangements for the quality reports and metadata pursuant to Regulation (EU) 2025/941 of the European Parliament and of the CouncilCouncil Regulation (EU) 2026/1336 of 15 June 2026 amending Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Regulation (EU) 2026/1353 of 15 June 2026 amending Implementing Regulations (EU) 2020/617 and (EU) No 540/2011 as regards the conditions of approval of the active substance metalaxyl-MCouncil Implementing Regulation (EU) 2026/1356 of 15 June 2026 implementing Regulation (EU) 2024/2642 concerning restrictive measures in view of Russia’s destabilising activitiesCouncil Implementing Regulation (EU) 2026/1358 of 15 June 2026 implementing Regulation (EU) 2023/888 concerning restrictive measures in view of actions destabilising the Republic of MoldovaCouncil Implementing Regulation (EU) 2026/1361 of 15 June 2026 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Implementing Regulation (EU) 2026/1362 of 15 June 2026 implementing Regulation (EU) 2024/1485 concerning restrictive measures in view of the situation in RussiaCommission Implementing Regulation (EU) 2026/1280 of 12 June 2026 fixing the adjustment rate for direct payments pursuant to Regulation (EU) 2021/2116 of the European Parliament and of the Council in respect of the calendar year 2026

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next